Provided by Tiger Fintech (Singapore) Pte. Ltd.

The Gabelli Multimedia Trust Inc.

4.14
+0.07001.72%
Post-market: 4.140.00000.00%16:14 EDT
Volume:102.91K
Turnover:422.59K
Market Cap:148.50M
PE:11.33
High:4.14
Open:4.08
Low:4.08
Close:4.07
Loading ...

Mario J. Gabelli, Executive Chair, Reports Acquisition of Common Shares in The Gabelli Multimedia Trust Inc

Reuters
·
20 May

Press Release: CORRECTION -- Gabelli Multimedia Trust Reinforces Maintenance of $0.88 per Share Annual Distribution Continues Monthly Distributions

Dow Jones
·
15 May

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

GlobeNewswire
·
29 Apr

STEPN creator FSL launches GMT Pay, letting users spend crypto anywhere 6 seconds ago

cryptonews
·
29 Apr

Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication

GlobeNewswire
·
24 Apr

BRIEF-Gabelli Multimedia Trust Enters Sales Agreement To Sell Up To 5 Mln Shares

Reuters
·
23 Apr

Gabelli Multimedia Trust Inc - on April 16, Enters Sales Agreement to Sell up to 5 Mln Shares - SEC Filing

THOMSON REUTERS
·
23 Apr

Press Release: Gabelli Multimedia Trust Board Approves at the Market Common Stock Offerings With Prices Trading Above NAV

Dow Jones
·
10 Apr

Gabelli Multimedia Trust Reinforces Maintenance of $0.88 Per Share Annual Distribution Will Commence Monthly Distributions in May 2025

GlobeNewswire
·
10 Apr

Press Release: MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update

Dow Jones
·
20 Mar

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Business Wire
·
27 Feb

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

GlobeNewswire
·
18 Feb

UPDATE - United Kingdom Investment Trusts

GlobeNewswire
·
30 Jan

Discount Doctor to Visit United Kingdom in Support of Investment Trusts

GlobeNewswire
·
29 Jan

MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH

PR Newswire
·
18 Dec 2024

Gilead’s Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis

Business Wire
·
13 Dec 2024